首页> 外文期刊>Journal of Biomolecular Structure and Dynamics >Computational assessment of herbal medicine-derived compounds as potential inhibitors of SARS-CoV-2 main protease
【24h】

Computational assessment of herbal medicine-derived compounds as potential inhibitors of SARS-CoV-2 main protease

机译:草药衍生化合物作为 SARS-CoV-2 主要蛋白酶潜在抑制剂的计算评估

获取原文
获取原文并翻译 | 示例

摘要

Since the main protease (Mpro) is crucial for the COVID-19 virus replication and transcription, searching for Mpro inhibitors is one possible treatment option. In our study, 258 small molecules were collected from lung-related herbal medicines, and their structures were optimized with the B3LYP-D3/6-31G* method. After the molecular docking with Mpro, we selected the top 20 compounds for the further geometry optimization with the larger basis sets. After the further molecular docking, the top eight compounds were screened out. Then we performed molecular dynamics simulations and binding free energy calculations to determine stability of the complexes. Our results show that mulberrofuran G, Xambioona, and kuwanon D can bind Mpro well. In quantum chemistry studies, such as ESP and CDFT analyses, the compounds properties are predicted. Additionally, the drug-likeness analyses and ADME studies on these three candidate compounds verified that all of them conform to Libinski's rule and may be drug-like compounds.
机译:由于主要蛋白酶 (Mpro) 对 COVID-19 病毒的复制和转录至关重要,因此寻找 Mpro 抑制剂是一种可能的治疗选择。本研究收集了258个与肺部相关的草药小分子,并采用B3LYP-D3/6-31G*方法对其结构进行了优化。在与Mpro进行分子对接后,我们选择了前20种化合物,以使用更大的基础集进行进一步的几何优化。经过进一步的分子对接后,筛选出前8种化合物。然后,我们进行了分子动力学模拟和结合自由能计算,以确定配合物的稳定性。结果表明,桑呋喃G、Xambioona和kuwanon D可以很好地结合Mpro。在量子化学研究中,例如ESP和CDFT分析,可以预测化合物的性质。此外,对这三种候选化合物的药物相似性分析和ADME研究证实,它们都符合Libinski规则,可能是类药物化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号